Novamedas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 3,736,644 | 2,196,452 | 3,332,864 | 1,096,389 | 4,918,888 | 4,649,976 | 5,018,165 | 5,529,692 |
| Profit before tax | 45,946 | 4,080 | 27,207 | 57,863 | 127,856 | 294,751 | 640,174 | 726,658 |
| Net profit | 39,048 | 3,304 | 22,049 | 46,714 | 104,817 | 250,537 | 532,815 | 609,196 |
| Equity | 42,653 | 45,611 | 67,660 | 105,785 | 210,602 | 552,582 | 849,111 | 1,458,307 |
| Liabilities | 657,758 | 510,796 | 523,310 | 0 | 2,919,493 | 1,733,202 | 1,225,097 | 1,819,775 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 700,411 | 556,407 | 590,970 | 747,041 | 3,130,095 | 2,285,712 | 2,074,135 | 3,277,991 |
| Total assets | 700,411 | 556,407 | 590,970 | 747,041 | 3,130,095 | 2,285,712 | 2,074,135 | 3,277,991 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 55,867 | 84,110 | 168,709 |
| Social insurance contributions | - | - | - | - | - | 48,462 | 48,305 | 45,928 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +414.6% | -41.2% | +51.7% | -67.1% | +348.6% | -5.5% | +7.9% | +10.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 5.6% | 0.6% | 3.7% | 6.3% | 3.3% | 11.0% | 25.7% | 18.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 91.5% | 7.2% | 32.6% | 44.2% | 49.8% | 45.3% | 62.7% | 41.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.0% | 0.2% | 0.7% | 4.3% | 2.1% | 5.4% | 10.6% | 11.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.2% | 0.2% | 0.8% | 5.3% | 2.6% | 6.3% | 12.8% | 13.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 15.4 | 11.2 | 7.7 | - | 13.9 | 3.1 | 1.4 | 1.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 773,104 | 325,400 | 476,123 | 180,229 | 881,000 | 962,071 | 1,003,633 | 965,497 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Novamedas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-07-16 | 2024-07-24 | 0.08 |
| 2024-06-18 | 2024-07-01 | 0.06 |
| 2024-05-16 | 2024-06-03 | 0.04 |
| 2024-04-16 | 2024-05-01 | 0.02 |
| 2023-12-20 | 2023-12-26 | 0.01 |
| 2023-10-17 | 2023-11-06 | 90.81 |
| 2023-09-18 | 2023-10-12 | 0.56 |
| 2023-08-17 | 2023-09-06 | 0.56 |
| 2023-07-18 | 2023-08-06 | 0.55 |
| 2023-06-16 | 2023-07-09 | 0.55 |
| 2023-05-16 | 2023-06-07 | 0.55 |
| 2023-05-02 | 2023-05-07 | 0.55 |
| 2023-04-26 | 2023-04-28 | 0.55 |
| 2023-04-18 | 2023-04-25 | 0.25 |
| 2023-03-16 | 2023-04-03 | 0.23 |
| 2023-02-17 | 2023-03-02 | 0.23 |
| 2023-02-06 | 2023-02-14 | 0.23 |
| 2023-01-24 | 2023-02-03 | 0.23 |
| 2023-01-20 | 2023-01-22 | 0.23 |
| 2023-01-17 | 2023-01-19 | 252.33 |
| 2022-12-16 | 2022-12-21 | 15.58 |
| 2022-11-21 | 2022-12-01 | 0.05 |
| 2022-11-17 | 2022-11-18 | 0.05 |
| 2022-10-28 | 2022-11-03 | 0.04 |
| 2022-10-18 | 2022-10-23 | 94.50 |
| 2022-09-16 | 2022-10-03 | 94.49 |
Novamedas - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Novamedas, UAB (code 304536799) is a private limited liability company engaged in the wholesale of other machinery and equipment. In 2025, the latest financial year, the company generated revenue of €5.53M, up 10.2% year on year and 18.9% over two years. Net profit increased to €609.2K, compared with €532.8K in 2024 and €250.5K in 2023, showing a clear three-year upward trend in earnings. The profit margin improved from 5.4% in 2023 to 10.6% in 2024 and 11.0% in 2025, indicating stronger operational efficiency. Balance sheet strength also improved, with equity rising to €1.46M in 2025 from €849.1K in 2024 and liabilities at €1.82M. Total assets increased to €3.28M. Key ratios for 2025 show a ROE of 41.8%, ROA of 18.6%, a debt-to-equity ratio of 1.25, and asset turnover of 1.69x. Revenue per employee reached €1.11M, while profit per employee was €121.8K.